HPTN 035 phase II/IIb randomised safety and effectiveness study of the vaginal microbicides BufferGel and 0.5% PRO 2000 for the prevention of sexually transmitted infections in women.

Guffey, M Bradford.Richardson, Barbra Ann.Husnik, Marla.Makanani, Bonus.Chilongozi, David.Yu, Elmer.Ramjee, Gita.Mgodi, Nyaradzo.Gomez, Kailazarid.Hillier, Sharon Louise.Abdool Karim, Salim Safurdeen.2016-11-082016-11-0820142014Guffey, M.B., Richardson, B., Husnik, M., Makanani, B., Chilongozi, D., Yu, E., Ramjee, G., Mgodi, N., Gomez, K., Hillier, S.L. and Abdool Karim, S.S. 2014. HPTN 035 phase II/IIb randomised safety and effectiveness study of the vaginal microbicides BufferGel and 0.5% PRO 2000 for the prevention of sexually transmitted infections in women. Sexually transmitted infections 90(5), 363-369.http://dx.doi.org/10.1136/sextrans-2014-051537http://hdl.handle.net/10413/13611CAPRISA, 2014.Abstract available in pdf.enNeisseria gonorrhoeae.Chlamydia trachomatis.Trichomonas.Microbicides.Prevention.HPTN 035 phase II/IIb randomised safety and effectiveness study of the vaginal microbicides BufferGel and 0.5% PRO 2000 for the prevention of sexually transmitted infections in women.Peer reviewed journal article